Courtesy of Benzinga
The Associated Press reports that Icagen (NASDAQ: ICGN) is rising on merger speculation with Pfizer (NYSE: PFE). The Reuters story on the AP article can be found via the link above. At last check, shares of Icagen were trading over 133% higher in pre-market trading versus Friday’s closing price.